Results 161 to 170 of about 4,877,471 (249)

PF655 PROGNOSTIC RELEVANCE OF THE GENE EXPRESSION SIGNATURE IN PRIMARY AND SECONDARY MYELOFIBROSIS

, 2019
Sebastiano Rontauroli, Roberta Zini, Elisa Bianchi, Elena Genovese, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Selene Mallia, Sara Castellano, Paola Guglielmelli, Daniela Pietra, Elisa Rumi, Silvia Salmoiraghi, Federica Delaini, Barbara Mora, L. Elli, Raffaella Accetta, Laura Villani, C Azzan, Vittorio Rosti, Francesco Passamonti, Alessandro Rambaldi, Mario Cazzola, Alessandro M. Vannucchi, Enrico Tagliafico, Rossella Manfredini   +25 more
openalex   +1 more source

Application of Cytostatic Therapy in Patients with Primary Myelofibrosis in Young Age

, 2022
Abdiev Kattabek Makhmatovich, Akhmedov Khusan Isrofilovich   +1 more
openalex   +1 more source

Pulmonary arterial hypertension exacerbated by ruxolitinib [PDF]

, 2015
Harrison, C, Howard, L, Low, AT, Tulloh, RMR   +3 more
core   +2 more sources

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia [PDF]

, 2011
Alessandra Carobbio, Guido Finazzi, Jüergen Thiele, Hans Michael Kvasnicka, Francesco Passamonti, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, Elisabetta Antonioli, Heinz Gisslinger, Veronika Buxhofer‐Ausch, Naseema Gangat, Alessandro Rambaldi, Ayalew Tefferi, Tiziano Barbui   +17 more
openalex   +1 more source

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

Journal of Clinical Oncology, 2017
P. Guglielmelli, T. Lasho, G. Rotunno, M. Mudireddy, C. Mannarelli, M. Nicolosi, Annalisa Pacilli, A. Pardanani, E. Rumi, V. Rosti, C. Hanson, F. Mannelli, R. Ketterling, N. Gangat, A. Rambaldi, F. Passamonti, G. Barosi, T. Barbui, M. Cazzola, A. Vannucchi, A. Tefferi   +20 more
semanticscholar   +1 more source

Hereditary spherocytosis concomitant with JAK2V617F-positive primary myelofibrosis: a case report. [PDF]

Front Oncol
Qiu CE, Lei L, Jiang G, Huang X, Li Y.
europepmc   +1 more source

Programmed death‐ligand 1 expression in patients with primary or secondary myelofibrosis

Moayed Ibrahim, Catherine R. Murphree, Kirtesh R. Patel, Matthew Mastrodomenico, Nakhle S. Saba, Hana Safah, Janet Schmid, Francisco Socola   +7 more
openalex   +1 more source

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis [PDF]

, 2018
Maura Nicolosi, Mythri Mudireddy, Mrinal M. Patnaik, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi   +5 more
openalex   +1 more source

Inhibiting the alarmin-driven hematopoiesis-stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis. [PDF]

Hemasphere
Gleitz HFE, Fuchs SNR, Snoeren IAM, Boys C, Nagai J, Tejeda-Mora H, Klöker V, Pritchard JE, Bakker IJ, Gargallo Garasa M, Bindels E, Saez-Rodriguez J, Vogl T, Kramann R, Dugourd A, Costa IG, Schneider RK.   +16 more
europepmc   +1 more source

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial [PDF]

, 2017
DiPersio, John F, et al,
core   +1 more source